Seeking Clues to Manpower (MAN) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

Wall Street analysts anticipate ManpowerGroup (MAN) to report Q2 earnings of $0.69 per share, a substantial 46.9% year-over-year decrease, on revenues of $4.35 billion, down 3.7%. The consensus EPS estimate has remained unchanged over the past 30 days, reflecting analysts' consistent outlook despite projected declines across most service revenue segments and operating profits in key regions. While facing these anticipated headwinds, MAN shares have recently outperformed the S&P 500, gaining 9.4% over the last month.

Analysis

Wall Street projects a significant contraction for ManpowerGroup's (MAN) upcoming Q2 results, with consensus estimates pointing to a 46.9% year-over-year decline in earnings per share to $0.69 and a 3.7% revenue decrease to $4.35 billion. The anticipated revenue weakness appears broad-based, led by a steep 9.1% projected decline in Northern Europe and a 6.2% drop in the APME region. The Americas are also expected to shrink by 3.5%. A notable exception is Southern Europe, where growth in Italy (+3.1%) and other smaller markets is expected to partially offset a significant 5.1% contraction in France, leading to a more modest overall regional decline of 1.6%. This top-line pressure is forecast to impact profitability, with operating profits expected to fall across all major geographic units. Despite these bearish projections, which have remained stable for the past 30 days, MAN's stock has rallied 9.4% over the past month, creating a potential disconnect between recent market optimism and the fundamental outlook.

Key Decisions for Investors

• Investors should approach the upcoming earnings announcement with caution, as the stock's recent 9.4% outperformance appears disconnected from the consensus forecast for a sharp 46.9% decline in EPS.
• Pay close attention to the geographic revenue breakdown, particularly whether the projected resilience in Italy (+3.1%) materializes and how severe the contraction is in Northern Europe (-9.1%), as this will be a key indicator of underlying market health.
• Forward guidance will be critical; given the expected weak Q2 results and stable analyst estimates, any deviation in the company's outlook for the second half of the year will likely be the primary catalyst for the stock's direction post-release.